Inventor · disambiguated record
Klaus Kaluza
Also filed as: KALUZA KLAUS
45 granted patents·11 pending applications·335 citations·filing 1989–2023
98Inventor score
Files withHOFFMANN LA ROCHE35BOEHRINGER MANNHEIM GMBH9BRINKMANN ULRICH3FERTIG GEORG3ANGELIKA ESSWEIN WOLFGANG SCHA1
Top patents by PatentIndex Score
56 records- 0195US9499625B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·33 claims
- 0295US8133979B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2009·Granted Mar 13, 2012·19 cites·10 claims
- 0394US9879085B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Jan 30, 2018·10 cites·20 claims
- 0494US9663580B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted May 30, 2017·11 cites·20 claims
- 0594US9499626B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·31 claims
- 0693US9624302B2Nucleic acids encoding antibodies against human CSF-1RHOFFMANN LA ROCHE·Filed 2015·Granted Apr 18, 2017·11 cites·11 claims
- 0793US9617342B2Nucleic acids encoding antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Apr 11, 2017·11 cites·9 claims
- 0893US9499624B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Nov 22, 2016·12 cites·15 claims
- 0992US9890209B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Feb 13, 2018·10 cites·8 claims
- 1092US9221910B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Dec 29, 2015·20 cites·12 claims
- 1192US8361747B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2012·Granted Jan 29, 2013·10 cites·4 claims
- 1291US10077314B1Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Sep 18, 2018·5 cites·20 claims
- 1391US10072087B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Sep 11, 2018·5 cites·20 claims
- 1491US9169323B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Oct 27, 2015·13 cites·15 claims
- 1591US8399626B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2012·Granted Mar 19, 2013·9 cites·5 claims
- 1690US9988458B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jun 5, 2018·6 cites·14 claims
- 1789US10030073B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·5 cites·23 claims
- 1889US8999327B2Antibodies against human CSF-1R and uses thereofDIMOUDIS NIKOLAOS·Filed 2010·Granted Apr 7, 2015·16 cites·10 claims
- 1988US10287358B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted May 14, 2019·3 cites·20 claims
- 2088US9670274B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Jun 6, 2017·6 cites·8 claims
- 2188US9493553B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Nov 15, 2016·8 cites·8 claims
- 2287US2023227543A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2386US9309319B2Antibodies against human IL33R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Apr 12, 2016·8 cites·7 claims
- 2484US10336830B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·15 claims
- 2584US9340609B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2012·Granted May 17, 2016·3 cites·5 claims
- 2683US10023643B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2012·Granted Jul 17, 2018·5 cites·7 claims
- 2783US8883975B2Antibodies against IL-18R1 and uses thereofBRANDT MICHAEL·Filed 2011·Granted Nov 11, 2014·14 cites·22 claims
- 2881US9109027B2Antibodies against human angiopoietin 2BRINKMANN ULRICH·Filed 2012·Granted Aug 18, 2015·2 cites·2 claims
- 2980US2020262904A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3078US2021388071A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3177US7786113B2Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Aug 31, 2010·3 cites·9 claims
- 3277US7618964B2Benzamide derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Nov 17, 2009·3 cites·11 claims
- 3376US6187575B1Thermolabile uracil-DNA-glycosylas, process for its preparation and use for removing uracil from DNAROCHE DIAGNOSTICS GMBH·Filed 1996·Granted Feb 13, 2001·36 cites·30 claims
- 3471US2019300614A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3570US10647761B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted May 12, 2020·0 cites·8 claims
- 3669US2018282404A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3766US9073986B2Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2013·Granted Jul 7, 2015·0 cites·6 claims
- 3864US2015080556A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3964US2017029493A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4063US10316082B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Jun 11, 2019·0 cites·8 claims
- 4161US6673816B1Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disordersESSWEIN ANGELIKA·Filed 1999·Granted Jan 6, 2004·9 cites·3 claims
- 4261US2015284457A1Antibodies against human angiopoietin 2HOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 4354US5856156AMicrobial cholesterol dehydrogenase, process for its production and useBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Jan 5, 1999·12 cites·7 claims
- 4453US8785153B2Antibodies against human IL33R and uses thereofFERTIG GEORG·Filed 2012·Granted Jul 22, 2014·0 cites·16 claims
- 4553US2017275368A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 4650US7956190B2Benzimidazole amido derivatives as kinase inhibitorsHOFFMANN LA ROCHE·Filed 2008·Granted Jun 7, 2011·0 cites·10 claims
- 4746US2003032813A1Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disordersANGELIKA ESSWEIN WOLFGANG SCHA·Filed 2002·Application pending·0 cites
- 4844US5506216ACyclodextrin-biocide complexBOEHRINGER MANNHEIM GMBH·Filed 1994·Granted Apr 9, 1996·10 cites·11 claims
- 4943US2011218199A1Pyridoneamide derivatives, their manufacture and use as pharmaceutical agentsGEORGES GUY·Filed 2008·Application pending·0 cites
- 5040US5354669AType II restriction endonuclease SexAIBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Oct 11, 1994·4 cites·10 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Klaus Kaluza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →